Mar 24, 2026 8:00am EDT LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Mar 17, 2026 8:00am EDT LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
Mar 10, 2026 8:00am EDT LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
Jan 14, 2026 8:30am EST LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
Jan 07, 2026 5:08pm EST LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
Jan 05, 2026 8:00am EST LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East
Dec 01, 2025 8:30am EST LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
Nov 05, 2025 8:00am EST LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights